Viewing Study NCT05002816

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:47 AM
Ignite Modification Date: 2026-02-23 @ 8:56 PM
Study NCT ID: NCT05002816
Status: RECRUITING
Last Update Posted: 2025-10-30
First Post: 2021-07-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
Sponsor: Yale University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Belantamab Mafodotin View
None Elotuzumab View